Literature DB >> 7913421

Comparative effects of taxol and Taxotere on two different human carcinoma cell lines.

P Garcia1, D Braguer, G Carles, S el Khyari, Y Barra, C de Ines, I Barasoain, C Briand.   

Abstract

The effects of taxoids (taxol and Taxotere) were followed on two human cancerous cell lines (bladder carcinoma J82 cells and epidermoid carcinoma KB 3-1 cells). Three cellular parameters were studied, viz., the qualitative effect on cellular microtubules, the quantitation of tubulin, and the antimitotic action, using two-parametric flow-cytometric analyses in treated cells. In both of the cell lines the tubulin content increased after taxoid treatment before the accumulation of cells in the G2/M phase. The effects of taxoids on tubulin appeared at about a 10-fold lower concentration on KB cells than on J82 cells. After drug exposure, the microtubule network showed a striking difference between the two cell lines: microtubule bundles were predominant in the J82 cell line, whereas multiple asters were prevalent in the KB cell line. The formation of these structures was dose- and time-dependent. Asters were observed in mitotic cells and bundles were seen in interphase cells. The reversibility of these structures in both cell lines varied with the duration of exposure to drug. Some differences were shown between taxol and Taxotere: the effects of Taxotere as compared with taxol appeared at a 2-fold lower concentration and their reversibility was slower.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7913421     DOI: 10.1007/bf00686042

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  17 in total

1.  Method for the quantitative evaluation of data from flow microfluorometry.

Authors:  J Fried
Journal:  Comput Biomed Res       Date:  1976-06

2.  Interaction of tubulin and cellular microtubules with the new antitumor drug MDL 27048. A powerful and reversible microtubule inhibitor.

Authors:  V Peyrot; D Leynadier; M Sarrazin; C Briand; A Rodriquez; J M Nieto; J M Andreu
Journal:  J Biol Chem       Date:  1989-12-15       Impact factor: 5.157

Review 3.  Taxol: an antimitotic agent with a new mechanism of action.

Authors:  J J Manfredi; S B Horwitz
Journal:  Pharmacol Ther       Date:  1984       Impact factor: 12.310

4.  Microtubule stability and assembly in living cells: the influence of metabolic inhibitors, taxol and pH.

Authors:  M De Brabander; G Geuens; R Nuydens; R Willebrords; J De Mey
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1982

5.  Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue.

Authors:  M C Bissery; D Guénard; F Guéritte-Voegelein; F Lavelle
Journal:  Cancer Res       Date:  1991-09-15       Impact factor: 12.701

6.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

7.  Comparative in vitro cytotoxicity of taxol and Taxotere against cisplatin-sensitive and -resistant human ovarian carcinoma cell lines.

Authors:  L R Kelland; G Abel
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

8.  Direct photoaffinity labeling of tubulin with taxol.

Authors:  S Rao; S B Horwitz; I Ringel
Journal:  J Natl Cancer Inst       Date:  1992-05-20       Impact factor: 13.506

Review 9.  Taxol: a novel investigational antimicrotubule agent.

Authors:  E K Rowinsky; L A Cazenave; R C Donehower
Journal:  J Natl Cancer Inst       Date:  1990-08-01       Impact factor: 13.506

10.  Development of polyploidization in taxol-resistant human leukemia cells in vitro.

Authors:  J R Roberts; D C Allison; R C Donehower; E K Rowinsky
Journal:  Cancer Res       Date:  1990-02-01       Impact factor: 12.701

View more
  13 in total

Review 1.  Contemporary agents in the management of metastatic castration-resistant prostate cancer.

Authors:  Anil Kapoor; Christopher Wu; Bobby Shayegan; Adrian P Rybak
Journal:  Can Urol Assoc J       Date:  2016-12-12       Impact factor: 1.862

2.  Radiation-sensitizing effect of low-concentration docetaxel on human esophageal squamous cell carcinoma cell lines.

Authors:  Satoshi Tabuchi; Soji Ozawa; Kazuo Koyanagi; Naoyuki Shigematsu; Atsushi Kubo; Masakazu Ueda; Yuko Kitagawa; Masaki Kitajima
Journal:  Exp Ther Med       Date:  2011-05-10       Impact factor: 2.447

3.  Cyclin D1 overexpression enhances chemosensitivity to TPF chemotherapeutic agents via the caspase-3 pathway in oral cancer.

Authors:  Yong-Jie Hu; Wen-Wen Sun; Tong-Chao Zhao; Ying Liu; Dong-Wang Zhu; Li-Zhen Wang; Jiang Li; Chen-Ping Zhang; Zhi-Yuan Zhang; Lai-Ping Zhong
Journal:  Oncol Lett       Date:  2020-08-24       Impact factor: 2.967

4.  Influence of microtubule-associated proteins on the differential effects of paclitaxel and docetaxel.

Authors:  Y Fromes; P Gounon; R Veitia; M C Bissery; A Fellous
Journal:  J Protein Chem       Date:  1996-05

5.  The mechanism of action of docetaxel (Taxotere) in xenograft models is not limited to bcl-2 phosphorylation.

Authors:  Lisa Ann Kraus; Shanti K Samuel; Steven M Schmid; Donald J Dykes; William R Waud; Marie Christine Bissery
Journal:  Invest New Drugs       Date:  2003-08       Impact factor: 3.850

Review 6.  Basal-like subtype and BRCA1 dysfunction in breast cancers.

Authors:  Yasuo Miyoshi; Keiko Murase; Koushi Oh
Journal:  Int J Clin Oncol       Date:  2008-10-23       Impact factor: 3.402

Review 7.  Advances in prostate cancer immunotherapies.

Authors:  Michael Basler; Marcus Groettrup
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

8.  Low nuclear grade but not cell proliferation predictive of pathological complete response to docetaxel in human breast cancers.

Authors:  Yasuo Miyoshi; Masafumi Kurosumi; Junichi Kurebayashi; Nariaki Matsuura; Masato Takahashi; Eriko Tokunaga; Chiyomi Egawa; Norikazu Masuda; Seung Jin Kim; Masatsugu Okishiro; Tetsu Yanagisawa; Satsuki Ueda; Tetsuya Taguchi; Yasuhiro Tamaki; Shinzaburo Noguchi
Journal:  J Cancer Res Clin Oncol       Date:  2007-10-16       Impact factor: 4.553

9.  Differentiation of human colon cancer cells changes the expression of beta-tubulin isotypes and MAPs.

Authors:  G Carles; D Braguer; C Dumontet; V Bourgarel; A Gonçalves; M Sarrazin; J B Rognoni; C Briand
Journal:  Br J Cancer       Date:  1999-06       Impact factor: 7.640

10.  Medicinal Plants: A Potential Source of Compounds for Targeting Cell Division.

Authors:  Ihsan N Zulkipli; Sheba R David; Rajan Rajabalaya; Adi Idris
Journal:  Drug Target Insights       Date:  2015-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.